{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:27:57Z","timestamp":1771010877707,"version":"3.50.1"},"reference-count":23,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"3910","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1969,12,5]]},"abstract":"<jats:p>Intracisternal injections of 6-hydroxydopamine produce rapid and long-lasting depletion of brain catecholamines without effects on serotonin concentrations. Depletion of norepinephrine is greatest in areas containing only nerve terminals and axons and least in areas containing monoamine cell bodies. The norepinephrine loss is accompanied by electron microscopic evidence of nerve terminal degeneration and decreased turnover. Dopamine loss is less marked and is not accompanied by degeneration or alteration of turnover rate.<\/jats:p>","DOI":"10.1126\/science.166.3910.1284","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T12:14:21Z","timestamp":1160050461000},"page":"1284-1286","source":"Crossref","is-referenced-by-count":373,"title":["Lesions of Central Norepinephrine Terminals with 6-OH-Dopamine: Biochemistry and Fine Structure"],"prefix":"10.1126","volume":"166","author":[{"given":"F. E.","family":"Bloom","sequence":"first","affiliation":[{"name":"Laboratories of Neuropharmacology and Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington. D.C. 20032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Algeri","sequence":"additional","affiliation":[{"name":"Laboratories of Neuropharmacology and Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington. D.C. 20032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Groppetti","sequence":"additional","affiliation":[{"name":"Laboratories of Neuropharmacology and Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington. D.C. 20032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Revuelta","sequence":"additional","affiliation":[{"name":"Laboratories of Neuropharmacology and Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington. D.C. 20032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Costa","sequence":"additional","affiliation":[{"name":"Laboratories of Neuropharmacology and Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington. D.C. 20032"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","reference":[{"key":"e_1_2_1_1_1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0006-8993(69)90286-8","volume":"13","year":"1969","unstructured":"AGHAJANIAN, G.K., ELECTRON MICROSCOPY OF DEGENERATION WITHIN SEROTONIN PATHWAY OF RAT BRAIN, BRAIN RESEARCH 13: 266 (1969).","journal-title":"BRAIN RESEARCH"},{"key":"e_1_2_1_2_1","first-page":"236","volume":"12","year":"1965","unstructured":"BLACKSTAD, T, JOURNAL OF ULTRASTRUCTURE RESEARCH 12: 236 (1965).","journal-title":"JOURNAL OF ULTRASTRUCTURE RESEARCH"},{"key":"e_1_2_1_3_1","first-page":"261","volume":"159","year":"1968","unstructured":"BLOOM, F.E., AN ELECTRON MICROSCOPIC ANALYSIS OF LARGE GRANULAR SYNAPTIC VESICLES OF BRAIN IN RELATION TO MONOAMINE CONTENT, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 159: 261 (1968).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/B978-1-4831-9684-8.50012-0","volume":"3","year":"1961","unstructured":"Crout, J. R., Standard Methods of Clinical Chemistry 3: 62 (1961).","journal-title":"Standard Methods of Clinical Chemistry"},{"key":"e_1_2_1_5_1","unstructured":"DAHLSTROM A ACTA PHYSIOLOGICA SCANDINAVICA 62 232 (1965)."},{"key":"e_1_2_1_6_1","first-page":"309","volume":"96","year":"1962","unstructured":"GRAY, E.G., ELECTRON MICROSCOPY OF EXPERIMENTAL DEGENERATION IN AVIAN OPTIC TECTUM, JOURNAL OF ANATOMY 96: 309 (1962).","journal-title":"JOURNAL OF ANATOMY"},{"key":"e_1_2_1_7_1","first-page":"653","volume":"8","year":"1969","unstructured":"GROPPETTI, A, LIFE SCIENCES PART 1 PHYSIOLOGY AND PHARMACOLOGY AND PART 2 BIOCHEMISTRY GENERAL AND MOLECULAR BIOLOGY 8: 653 (1969).","journal-title":"LIFE SCIENCES PART 1 PHYSIOLOGY AND PHARMACOLOGY AND PART 2 BIOCHEMISTRY GENERAL AND MOLECULAR BIOLOGY"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1748-1716.1963.tb02739.x","volume":"59","year":"1963","unstructured":"HAGGENDAL, J, AN IMPROVED METHOD FOR FLUORIMETRIC DETERMINATION OF SMALL AMOUNTS OF ADRENALINE AND NORADRENALINE IN PLASMA AND TISSUES, ACTA PHYSIOLOGICA SCANDINAVICA 59: 242 (1963).","journal-title":"ACTA PHYSIOLOGICA SCANDINAVICA"},{"key":"e_1_2_1_9_1","first-page":"309","volume":"76","year":"1942","unstructured":"HERRMANN, J.B., J PHARMACOL EXP THER 76: 309 (1942).","journal-title":"J PHARMACOL EXP THER"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1054-3589(08)60326-9","volume":"6","year":"1968","unstructured":"JOUVET, M, ADV PHARMACOL 6: 265 (1968).","journal-title":"ADV PHARMACOL"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1476-5381.1965.tb01745.x","volume":"24","year":"1965","unstructured":"LAVERTY, R, ACTION OF 2, 4, 5-TRIHYDROXYPHENYLETHYLAMINE ON STORAGE AND RELEASE OF NORADRENALINE, BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 24: 549 (1965).","journal-title":"BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1054-3589(08)61153-9","volume":"6","year":"1968","unstructured":"LOVENBERG, W, ADV PHARMAC A 6: 21 (1968).","journal-title":"ADV PHARMAC A"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-2999(68)90056-3","volume":"3","year":"1968","unstructured":"MALMFORS, T, DEGENERATION OF ADRENERGIC NERVES PRODUCED BY 6-HYDROXYDOPAMINE, EUROPEAN JOURNAL OF PHARMACOLOGY 3: 89 (1968).","journal-title":"EUROPEAN JOURNAL OF PHARMACOLOGY"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00408180","volume":"4","year":"1963","unstructured":"MARTIN, W.R., TOLERANCE TO AND PHYSICAL-DEPENDENCE ON MORPHINE IN RATS, PSYCHOPHARMACOLOGIA 4: 247 (1963).","journal-title":"PSYCHOPHARMACOLOGIA"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0024-3205(66)90204-9","volume":"5","year":"1966","unstructured":"NEFF, N.H., LIFE SCI 5: 951 (1966).","journal-title":"LIFE SCI"},{"key":"e_1_2_1_16_1","first-page":"308","volume":"140","year":"1963","unstructured":"PORTER, C.C., EFFECT OF 6-HYDROXYDOPAMINE AND SOME OTHER COMPOUNDS ON CONCENTRATION OF NOREPINEPHRINE IN HEARTS OF MICE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 140: 308 (1963).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0006-2952(65)90102-4","volume":"14","year":"1965","unstructured":"SNYDER, S.H., A SENSITIVE AND SPECIFIC FLUORESCENCE ASSAY FOR TISSUE SEROTONIN, BIOCHEMICAL PHARMACOLOGY 14: 831 (1965).","journal-title":"BIOCHEMICAL PHARMACOLOGY"},{"key":"e_1_2_1_18_1","unstructured":"Spano P. F. in preparation."},{"key":"e_1_2_1_19_1","first-page":"86","volume":"147","year":"1965","unstructured":"SPECTOR, S, BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE AN INHIBITOR OF TYROSINE HYDROXYLASE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 147: 86 (1965).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_20_1","first-page":"599","volume":"18","year":"1966","unstructured":"SPECTOR, S, INHIBITORS OF ENDOGENOUS CATECHOLAMINE BIOSYNTHESIS, PHARMACOLOGICAL REVIEWS 18: 599 (1966).","journal-title":"PHARMACOLOGICAL REVIEWS"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02146956","volume":"24","year":"1968","unstructured":"TRANZER, J.P., AN ELECTRON MICROSCOPIC STUDY OF SELECTIVE ACUTE DEGENERATION OF SYMPATHETIC NERVE TERMINALS AFTER ADMINISTRATION OF 6-HYDROXYDOPAMINE, EXPERIENTIA 24: 155 (1968).","journal-title":"EXPERIENTIA"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","volume":"5","year":"1968","unstructured":"UNGERSTEDT, U, 6-HYDROXY-DOPAMINE INDUCED DEGENERATION OF CENTRAL MONOAMINE NEURONS, EUROPEAN JOURNAL OF PHARMACOLOGY 5: 107 (1968).","journal-title":"EUROPEAN JOURNAL OF PHARMACOLOGY"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/221557a0","volume":"221","year":"1969","unstructured":"URETSKY, N.J., EFFECTS OF 6-HYDROXYDOPAMINE ON NORADRENALINE-CONTAINING NEURONES IN RAT BRAIN, NATURE 221: 557 (1969).","journal-title":"NATURE"}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.166.3910.1284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T16:39:00Z","timestamp":1704991140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.166.3910.1284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1969,12,5]]},"references-count":23,"journal-issue":{"issue":"3910","published-print":{"date-parts":[[1969,12,5]]}},"alternative-id":["10.1126\/science.166.3910.1284"],"URL":"https:\/\/doi.org\/10.1126\/science.166.3910.1284","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1969,12,5]]}}}